NetworkNewsBreaks

WednesdayAug 14, 2019 10:05 am

NetworkNewsBreaks – Pressure BioSciences Inc. (PBIO) to Host Teleconference to Discuss Q2 2019 Financial Results and Provide Business Update

Pressure BioSciences (OTCQB: PBIO) (“PBI”), a leader in the development and sale of broadly enabling, pressure-based technology and products to the worldwide life sciences and other industries, on Tuesday announced that it will host a teleconference to discuss its second quarter 2019 financial results and to provide a business update. The teleconference is scheduled for 4:30 PM ET on Thursday, August 15, 2019, and will include a company presentation followed by a question and answer period. Interested parties may listen to the teleconference live by dialing (844) 602-0380 (North America); (862) 298-0970 (International) and entering the following verbal passcode for…

Continue Reading

WednesdayAug 14, 2019 9:57 am

NetworkNewsBreaks – Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) to Release Q1 Fiscal Year 2020 Financial Results and Host Earnings Call

Canopy Rivers (TSX.V: RIV) (OTC: CNPOF) on Tuesday announced its plans to report first quarter fiscal year 2020 financial results before markets open on Tuesday, August 27, 2019. According to the update, Canopy Rivers will host a conference call and audio webcast following release of its results. The company’s president and CEO Narbe Alexandrian and CFO Eddie Lucarelli will lead the call, slated to be held at 10:00 AM ET on August 27, 2019. Interested parties may register for and join the live audio webcast at http://nnw.fm/RMV6c and join the call by dialing (888)-390-0546. A replay of the call will…

Continue Reading

WednesdayAug 14, 2019 9:22 am

NetworkNewsBreaks – Endonovo Therapeutics Inc. (ENDV) Posts Q2 2019 Financial Results

Endonovo Therapeutics (OTCQB: ENDV) on Tuesday posted the company’s financial and operating results for the second quarter. The company reported revenues for the three months ended June 30, 2019 of $62,729, a sharp increase compared to $12,854 for the same period last year. Gross profits for the second quarter were $33,156, as compared to $12,304 for the same period last year. Endonovo also provided an update on the PEMF assets it acquired from Rio Grande Neurosciences for $4.5 million in December 2017. “I am pleased to announce we have executed the business plan and strategy we implemented after acquiring the…

Continue Reading

TuesdayAug 13, 2019 2:59 pm

NetworkNewsBreaks – Organigram Holdings Inc. (TSX.V: OGI) (NASDAQ: OGI) Develops Technology to Provide Rapid-Onset of Cannabinoid Effects

Organigram Holdings (TSX.V: OGI) (NASDAQ: OGI), the parent company of Organigram Inc., a leading licensed producer of cannabis, has developed a unique, proprietary nano-emulsification technology that is anticipated to deliver an initial onset of effects within 10 to 15 minutes for cannabis beverages (http://nnw.fm/eT5Y0). A recent article discussing the company reads, “Organigram focuses on high-quality, indoor-grown cannabis for both medical patients and adult-recreational users. Its proprietary technology allows for the development of products with a quick onset of the cannabinoid effect within 10 to 15 minutes. To determine the onset of the products, Organigram studied cannabinoid particles at a size…

Continue Reading

TuesdayAug 13, 2019 2:22 pm

NetworkNewsBreaks – SinglePoint Inc. (SING) Advancing Cannabis Initiatives

Technology and investment company SinglePoint (OTCQB: SING) engages in the acquisition of small to mid-sized firms, with a focus on new technologies. Through its SingleSeed subsidiary, the company provides products and services to the cannabis industry. An article discussing the company reads, “Moreover, by way of SingleSeed, one of its wholly owned subsidiaries, SinglePoint is providing products and services to the cannabis sector. SinglePoint is also looking to advance its cannabis initiatives in other ways. ‘Industrial-derived hemp has created a wave of new products and opportunities in which SinglePoint has been able to drive additional revenue and profit,’ SinglePoint President…

Continue Reading

TuesdayAug 13, 2019 1:34 pm

NetworkNewsBreaks – Sugarmade Inc. (SGMD) Prepares First Closing of BZRTH Acquisition; CEO to Call Special Shareholder Meeting

Sugarmade (OTCQB: SGMD), one of the largest publicly traded hydroponics supply companies moving into the industrial hemp space, today announced that it is now prepared to complete the first closing of its BZRTH, LLC acquisition. As a major supplier to the hydroponic and hemp cultivation sectors, BZRTH produces more than $30 million in annual revenues. In addition, the company is in the process of organizing a special meeting of shareholders to elect new directors, including at least two independent directors with no “material relationship” to the company. “It is an exciting time for Sugarmade, especially as the California licensing and…

Continue Reading

TuesdayAug 13, 2019 12:38 pm

NetworkNewsBreaks – Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF) Expanding Consumer Base through Microdosing Movement

Plus Products (CSE: PLUS) (OTCQX: PLPRF) is exploring and exploiting new opportunities to increase its reach within the cannabis industry. An article discussing the company reads, “Plus Products is continually looking toward new opportunities to expand its consumer base. This attention to rising opportunities is evident in a recent launch of a new product line that provides consumers with microdosing options (http://nnw.fm/2AsOX). The company’s commitment to quality and consistency builds trust with consumers who know what to expect from every PLUS gummy and mint. . . . The new microdosing mints provide consumers with the same exceptional culinary commitment, unique flavors…

Continue Reading

TuesdayAug 13, 2019 11:40 am

NetworkNewsBreaks – CMG Holdings Group, Inc. (CMGO) Releases Q2 2019 Financial Results, Provides Shareholder Update

CMG Holdings Group (OTC: CMGO) today announced financial results for the second quarter of 2019 and provided a shareholder update from the company’s CEO, Glenn Laken. Among other highlights, the company reported total revenues of $1.06 million, an increase of 358% over $232K from the same period of 2018. The company attributes the increased revenues to effective execution and financial management. In addition, the company noted that its primary operating subsidiary XA closed a six-figure contract with a prominent clothing retailer. “Overall, we have returned XA to strong growth and sustained profitability, which management projected heading into this year. With…

Continue Reading

TuesdayAug 13, 2019 10:33 am

NetworkNewsBreaks – Marijuana Company of America Inc. (MCOA) Announces Progress, Revenue Generation at Joint Venture Oregon Hemp Farm

Innovative hemp and cannabis corporation Marijuana Company of America (OTCQB: MCOA) together with joint venture partner Global Hemp Group Inc. (CSE: GHG) ( OTC: GBHPF) ( FRANKFURT: GHG) today announced that their joint venture subsidiary, Covered Bridge Acres Ltd. (“CBA”), has started generating revenue through operations at its hemp farm in Scio, Oregon. According to the update, CBA generated $525,500 in its first year of operation through a combination of the sales of raw biomass, plantlets, CBD crude oil and CBD distillate produced from various processing test runs, as well as other farm operations. In its most recent transaction, CBA…

Continue Reading

TuesdayAug 13, 2019 9:59 am

NetworkNewsBreaks – Genprex, Inc. (NASDAQ: GNPX) Announces Recent Achievements as Part of Overall Expansion Strategy

Clinical-stage gene therapy company Genprex (NASDAQ: GNPX) this morning announced its recent achievements as part of the company’s overall strategy to expand its clinical development programs and bring its lead drug candidate, Oncoprex(TM) immunogene therapy, to commercialization. Per the update, Genprex has published recent as well as historical achievements to its newly launched, interactive corporate timeline, which can be found on the company’s website. “Since Genprex’s IPO last year, we have made significant progress in many areas of the company, including progress toward expansion of our clinical programs and sponsored research, our manufacturing process development and scalability, and the growth…

Continue Reading